Benzinga | Jun 7, 2021 07:04AM EDT

Bruker Launches CE-IVD Quantitative Coronavirus Mid-Plex PCR Assay With Mutation Detection For Routine Variant Differentiation

Bruker Corporation (NASDAQ:BRKR) today announced the launch of the FluoroType SARS-CoV-2 varID Q assay -- a quantitative LiquidArray(r)mid-plexPCR panel. This novel assay panel also detects several important mutations to enable laboratories and hospitals to differentiate many major viral variants routinely on all positive samples. The very sensitive FluoroType SARS-CoV-2 varID Q diagnostic test detects the SARS-CoV-2 virus using three independent gene targets for high assay robustness, even in case of future additional mutations. The assay achieved a sensitivity of 98% and a specificity of 100% during its clinical performance evaluation study.